Vvax-001 (ViciniVax)

N/A

Report date: 2023/08/30 20:00:41

Base Information

Drug NameVvax-001 (ViciniVax)
Drug Alias NameSemliki Forest Virus Based Cancer VaccinerSFVeE6 7Vvax-001SFVeE6 7
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulantsProtein E7 inhibitorsProtein E6 inhibitors
TargetsProtein E7Protein E6
Therapy Area/IndicationsCervical Intraepithelial NeoplasiaPapillomavirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesVicinivaxUgnwg Gmbh (University Of Groningen North West Germany Gmbh)
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Medical Center GroningenVicinivaxUgnwg Gmbh (University Of Groningen North West Germany Gmbh)
Inactive CompaniesN/A
Active IndicationsCervical Intraepithelial NeoplasiaPapillomavirus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A